Time for new leaders at the Medicines Control Council
Until 1997 the Medicines Control Council (MCC) was an efficient and effective institution. It was recognised internationally for its excellence. When zidovudine (AZT), the first antiretroviral (ARV), was submitted for approval, the MCC recognised its life-saving potential and registered the drug in just a few weeks. Then in 1997 the chairperson, Peter Folb, stood firm…
·